Eric Schiller - 02 Jan 2026 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Jan 2026, 19:46:53 UTC
Prior SEC filing
15 Jan 2026
Next SEC filing
20 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Adams Attorney-In-Fact

Key filing fact

Eric Schiller filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 15 Jan 2026.

Key facts

  • This page summarizes Eric Schiller's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Jan 2026, 19:46.

Change

  • Previous filing in this sequence was filed on 15 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002105459 Primary reporting owner

Schiller Eric

Relationship
Chief Technology Officer
Address
C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH
Signature
/s/ Thomas Adams Attorney-In-Fact
Signature date
15 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRMD transaction

Common Stock

Award

Transaction value
$0
Shares
+76,426
Change %
Price
$0.000000
Shares after
76,426
Date
02 Jan 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRMD transaction Derivative

Option to buy Common Stock

Award

Transaction value
$0
Shares
+232,297
Change %
Price
$0.000000
Shares after
232,297
Date
02 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
232,297
Exercise price
$5.70
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of restricted stock issued as an employment inducement award that vest 25% annually commencing January 2, 2027, subject to acceleration as provided in his employment agreement.

Footnote F2

One-fourth will vest on January 2, 2027 and on each first, second and third anniversary thereof, subject to acceleration as provided in his employment agreement.

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .